Its effects on tumor growth and endometrial cancer progression are through suppression of COX-2, TNF-α, IL-1, ornithine decarboxylase (ODC) activity, DNA synthesis, and TxA2 [162,163,164]. The gene discussed is ODC1; the disease is endometrial cancer.